Jai Mashru, Marion Elligsen, Nick Daneman, Marie-Félixe Granger, Robert A Kozak, Xena X Li, Jerome A Leis, Philip W Lam
{"title":"两种抗菌药敏感性报告策略对治疗由低风险 AmpC 诱导菌引起的菌血症的影响。","authors":"Jai Mashru, Marion Elligsen, Nick Daneman, Marie-Félixe Granger, Robert A Kozak, Xena X Li, Jerome A Leis, Philip W Lam","doi":"10.1017/ash.2025.49","DOIUrl":null,"url":null,"abstract":"<p><p>In this retrospective study examining the treatment of low-risk AmpC-producing Enterobacterales bacteremia during two periods with different microbiology reporting strategies, reporting of ceftriaxone susceptibility was associated with a statistically significant decrease in carbapenem use as definitive therapy compared to when susceptibility was suppressed (21 vs 50%, <i>p</i> < 0.0001).</p>","PeriodicalId":72246,"journal":{"name":"Antimicrobial stewardship & healthcare epidemiology : ASHE","volume":"5 1","pages":"e70"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11869070/pdf/","citationCount":"0","resultStr":"{\"title\":\"Impact of two antimicrobial susceptibility reporting strategies on treatment of bacteremia caused by low-risk AmpC inducible organisms.\",\"authors\":\"Jai Mashru, Marion Elligsen, Nick Daneman, Marie-Félixe Granger, Robert A Kozak, Xena X Li, Jerome A Leis, Philip W Lam\",\"doi\":\"10.1017/ash.2025.49\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In this retrospective study examining the treatment of low-risk AmpC-producing Enterobacterales bacteremia during two periods with different microbiology reporting strategies, reporting of ceftriaxone susceptibility was associated with a statistically significant decrease in carbapenem use as definitive therapy compared to when susceptibility was suppressed (21 vs 50%, <i>p</i> < 0.0001).</p>\",\"PeriodicalId\":72246,\"journal\":{\"name\":\"Antimicrobial stewardship & healthcare epidemiology : ASHE\",\"volume\":\"5 1\",\"pages\":\"e70\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-02-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11869070/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Antimicrobial stewardship & healthcare epidemiology : ASHE\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1017/ash.2025.49\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antimicrobial stewardship & healthcare epidemiology : ASHE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/ash.2025.49","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
在这项回顾性研究中，在两个不同的微生物学报告策略期间，对低风险产ampc肠杆菌菌血症的治疗进行了研究，与抑制易感性时相比，头孢曲松易感性的报告与碳青霉烯类药物作为最终治疗的使用减少有统计学意义（21% vs 50%, p < 0.0001）。
Impact of two antimicrobial susceptibility reporting strategies on treatment of bacteremia caused by low-risk AmpC inducible organisms.
In this retrospective study examining the treatment of low-risk AmpC-producing Enterobacterales bacteremia during two periods with different microbiology reporting strategies, reporting of ceftriaxone susceptibility was associated with a statistically significant decrease in carbapenem use as definitive therapy compared to when susceptibility was suppressed (21 vs 50%, p < 0.0001).
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
